Clavomed Susp. (Co-amoxiclav)

TRADE NAME
Clavomed
INTERNATIONAL
NON-PATENTED NAME
Amoxicillin
аnd
clavulanic acid
CHEMICAL NAME
Amoxicillin (as thrihydrate)
(2S,5R,6R)-6-[(R)-(-)-2-amino-2-(p-hydroxyphenyl) acetylamido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]-heptane-2-carboxylic
acid trihydrate
Clavulanic acid (as potassium
salt)
Potassium
(Z)-(2R,5R)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0.]-heptane-2-carboxylate
PHARMACEUTICAL FORM
Powder for preparation of
suspension for oral use
COMPOSITION
Every 5 ml of suspension
contain
For dosage 156.25
mg /5 ml 312.5 mg /5ml
Active ingredients:
Amoxicillin trihydrate
equivalent to amoxicillin 125
mg 250 mg,
potassium clavulanate
equivalent to clavulanic acid 31.25 mg
62.5 mg.
Inactive ingredients:
xanthan gum, citric acid
anhydrous, sodium citrate dihydrate, aspartame, sodium benzoate, flavour agent
“Orange”, microcrystalline cellulose, silicon dioxide.
АТС
CODE
J01CR02
PHARMACOTHERAPEUTIC
GROUP
Antibiotic for system
application. Group of semisynthetic penicillin containing inhibitor of
β-lactamase
of clavulanic acid.
PHARMACOLOGIC PROPERTIES
PHARMACODYNAMICS
Clavomed
suspension presents a combination of amoxicillin (semisynthetic penicillin with
a broad spectrum of antibacterial activity) and clavulanic acid (irreversible
inhibitor of β-
lactamases).
Clavulanic acid
forms a stable inactivated complex with stated ferments and protects
amoxicillin both against the loss of antibacterial activity due to the
production of β-
lactamases as the main pathogens and copathogens, and conditionally pathogen
organisms. Clavulanic acid has an antibacterial activity.
Amoxicillin
has a broad spectrum of antibacterial activity. It active in relation to such
sensitive to amoxicillin strains and in relation to the strains producing
β-lactamases:
Gram-positive
microorganisms:
Bacillis anthracis, Corynebacterium spp., Enterococcus faecalis,
Enterococcus faecium, Listeria monocytogenes, Nocardia asteroides,
Staphylococcus aureus, coagulase-negative staphylococcus (including
Staphylococcus epidermidis), Streptococcus spp. (including Streptococcus
agalactiae, Streptococcus pneumoniae, Streptococcus pyogenes, Streptococcus
viridans);
Gram-negative
microorganisms:
Bordetella pertussis, Brucella spp., Escherichia coli, Gardnerella vaginalis,
Haemophilus influenzae, Helicobacter pylori, Klebsiella spp., Legionella spp.,
Moraxella catarrhalis (Branhamella catarrhalis), Neisseria gonorrhoeae,
Neisseria meningitidis, Pasteurella multocida, Proteus mirabilis, Proteus
vulgaris, Salmonella spp., Shigella spp., Vibrio cholerae, Yersinia
enterocolitica;
Anaerobes:
Bacreroides spp., Clostridium spp., Peptococcus spp.,
Peptostreptococcus spp., Actinomyces israelli.
pharmacokinetics
The main pharmacokinetic parameters of amoxicillin and clavulanic acid are
similar. After intake, both components have a good absorption; the food intake
doesn’t influence on the absorption degree.
therapeutic
indicationS
Clavomed
suspension is prescribed for treatment of the following infections, caused by
the sensitive to the combination of amoxicillin/ clavulanic acid strains:
- infection of the wind-pipes upper sections
(acute and chronic
sinusitis, acute and chronic otitis media, tonsillopharyngitis);
- infections of the bottom departments of respiratory ways
(acute and chronic
bronchitis and pneumonias, empyema);
- urinary tracts infections (including cystitis, urethritis and pyelonephritis);
- gynecological infections (including salpingitis, salpingoophoritis,
endometritis, septic abortion, pelvioperitonitis);
- bone and connective tissues infections (including chronic osteomyelitis);
- skin and soft tissues infections (including phlegmon, traumatic fever);
- biliary tracts infections (cholecystitis, cholangitis);
- sexually transmitted diseases (gonorrhea, chancroid);
- odontogenic infections;
- infection prophylaxis after surgical operation.
CONTRAINDICATIONS
- hypersensitivity to
penicillin antibiotics;
- cholestatic jaundice or hepatitis;
- liver impairment;
- infectious monoucleos, lymphatic leukemia.
SPECIAL INDICATIONS
Due to the possible
development of cross sensitive, it is prescribed with cautious to the patients
with allergic reactions on cephalosporins, penicillins and other
allergens in patient’s anamnesis.
It is necessary to avoid the
application of Clavomed at suspicion on infectious mononucleosis as in
such cases amoxicillin can cause enanthesis, that complicates disease
diagnostics.
Patients with liver dysfunction
are necessary to use Clavomed cautiously.
Crystalluria occurs very seldom
among the patients with lowered diuresis, mainly at parenteral therapy. It is
recommended to accept enough of a liquid and to support adequate diuresis when
taking amoxicillin in high doses for reduction of crystals amoxicillin formation
probability.
It is
recommended to supervise periodically kidneys, liver functions, and hematosis
during the long therapy by Clavomed
Influence on ability for
driving and for operating with other mechanisms
Clavomed
doesn’t influence on the ability to drive and to operate with the mechanisms
demanding the high psychomotor action rate.
SIDE
EFFECTS
Side effects are weak and quickly
passing in most cases.
From the digestive
system: appetite loss,
nausea, vomiting, diarrhoeia.
Such undesirable effects can be avoided by taking Clavomed
suspension while eating.
Allergic reactions:
itch, appearance of skin rash; in single
cases: Stevens-Johns syndrome.
Others:
single reports about the appearance of cholestatic jaundice,
hepatitis, liver dysfunction, superinfection development (including candidosis),
reversible augmentation of prothrombine time.
DOSAGE AND ADMINISTRATION
For oral administration.
Shake the suspension before every use!
Directions for reconstitution:
Dissolve the powder in 100 ml of boiled and cooled water in
two portions (to the mark on the bottle) and shake well after each addition.
Clavomed
should be used while eating for possible side digestive reactions prevention.
For infants and children under 3 months:
standard dose makes 30 mg
(amoxicillin)/kg of body weight/day, divided in 2 doses.
Children from 3 months and older (body weight is less than 40
kg):
The recommended doses of suspensions (156.25 mg/ml and 312.5
mg/ml) are determined against the body weight of children and infection
severity. Usage: 3 times/day.
|
Body weight
(kg) |
Age |
Infections of middle
severity |
Sever infections |
|
Suspension |
Suspension |
|
156.25
mg/5
ml |
312.5
mg/5ml |
156.25
mg/5
ml |
156.25
mg/5
ml |
|
Single dose
(measuring spoon) |
|
5-10 |
3-12
months |
½ |
¼ |
¾ |
¼ - ½ |
|
10-12 |
1-2
years |
¾ |
¼ - ½ |
1¼ |
½ - ¾ |
|
12-15 |
2-4
years |
1 |
½ |
1½ |
¾ |
|
15-20 |
4-6
years |
1 ¼ |
½ - ¾ |
1¾ - 2 |
1 |
|
20-30 |
6-10
years |
1¾ |
¾ - 1 |
- |
1¼ - 1½ |
|
30-40 |
10-12
years |
- |
1¼ |
- |
1¾ - 2 |
|
≥ 40 |
≥ 12
years |
Tablets- dosage form
is used. |
Maximum daily dose of amoxicillin
makes for adults 6 g and 45 mg/kg
of body weight for children.
Maximum daily dose of clavulanic acid
(as potassium salt) makes for adults 600 mg and 10 mg/kg of body weight for
children.
For the patients with severe renal
insufficiency (creatinine clearance 10-30 ml/min)
must be sufficiently lowered the dose or increased the interval between intakes.
The treatment with Clavomed suspension can continue
during 14 days. Then, the patient should visit his/her doctor.
OVERDOSE
Sympthoms:
gastrointestinal disorders
and water-electrolytic balance disturbances can occur. Amoxicillin crystalluria
is described, in some cases leading to the development of renal insufficiency.
Treatment:
symptomatic therapy, correction of water-electrolytic balance. Clavomed
is removed from blood by hemodialysis.
interaction
WITN OTHER MEDICAMENTS
Co-application of Clavomed suspension and methotrexate raises the
toxicity of the last. The prescription with allopurinol raises the
frequency of appearance skin rash (exanthema).
In some cases Clavomed suspension can prolong the
prothrombin time; in connection with it one should be cautious at concomitant
prescription of anticoagulants and Clavomed.
One should avoid the co-application with disulphiram.
Clavomed
suspension should not be applied in combination with
bacteriostatic antibiotics (macrolides, tetracyclines), with
sulphanilamides due to the possible lowering of effectiveness of the
preparation.
It is antagonistic in combination with rimfampicine.
It is shown that antibiotics lower the effectiveness of
peroral contraceptives.
Probenecid
lowers the elimination of amoxicillin,
increasing its serum concentration.
APPLICATION DURING
PREGNANCY AND BREAST-FEEDING
Clavomed
can be taken during the pregnancy, if expected benefit for mother exceeds its
potential risk for foetus.
Only small amounts of amoxicillin and clavulanic acid are
excreted in breast milk, therefore during the treatment with Clavomed one
should cease the breast feeding.
PACKAGING
Powder for preparation of
suspension for oral use 156.25 mg/5ml or 312.5 mg/5 ml.
Polyethylene vial 100 ml, closed by stopper with protection
ring.
1 vial with measuring spoon in carton box together with
enclosed insert.
STORAGE CONDITIONS
Store in a dry place at the
temperature not exceeding 25ºС.
Store the reconstituted suspension at the
temperature from 2°С
to 8°С.
It must be used within 7 days.
Keep out of reach of children.
SHELF
LIFE
2 years from the manufacture
date.
Do not use if the labeled working life is expired.
SALES TERMS
Sold under prescription.
|